Azin Alizadehasl, Head of the Cardio-Oncology Department and Research Center at Rajaie Cardiovascular Medical and Research Center, shared her excitement about the positive reception of her team's recent research.
We’re thrilled that our recent 'Nature' publication has received such great feedback.
The publication focuses on radiomics methods for assessing cardiotoxicity in patients following chemotherapy. The study highlights an important intersection between oncology and cardiology, aiming to improve patient outcomes through advanced imaging and data analysis.
Further mentions of Azin Alizadehasl appear across professional networks, reflecting her growing influence in cardio-oncology research.
The recognition of Azin Alizadehasl's radiomics study on post-chemotherapy cardiotoxicity underscores the growing synergy between cancer treatment and cardiac care innovations.